A Many-Faced Alkaloid: Polymorphism of (-)-Monophyllidin.
alkaloid
chelate.
hydrogen bonding
monophyllidin
natural product
polymorphism
zanthoxylum
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
21 Jan 2020
21 Jan 2020
Historique:
received:
20
12
2019
revised:
15
01
2020
accepted:
16
01
2020
entrez:
25
1
2020
pubmed:
25
1
2020
medline:
6
11
2020
Statut:
epublish
Résumé
The synthesis of the alkaloid (-)-monophyllidin is described. The molecule is a hybrid of xanthoxyline and (S)-proline, accessible in one-step through a Mannich reaction. In the solid-state, defined structural arrangements with different physical properties are formed. Single crystal X-ray diffraction revealed structures of six distinct polymorphs. In the crystalline state, the alkaloid can host small polar molecules (preferably water), while the (S)-proline moiety is present in the zwitterionic state. Combined with the chelate, which is already present in the xanthoxyline substructure, an ideal disposition for multiple hydrogen bond networks evolve. Therefore, highly water-soluble polymorphs of monophyllidin can form. This structural flexibility explains the many faces of the molecule in terms of structure as well as analytical data. Furthermore, speculations about the biological role of the molecule, with regard to the manifold interactions with water, are presented.
Identifiants
pubmed: 31973223
pii: molecules25030449
doi: 10.3390/molecules25030449
pmc: PMC7037440
pii:
doi:
Substances chimiques
Acetonitriles
0
Alkaloids
0
Esters
0
Solvents
0
Water
059QF0KO0R
Ethanol
3K9958V90M
Oxygen
S88TT14065
acetonitrile
Z072SB282N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
pubmed: 18156677
J Appl Crystallogr. 2011 Dec 1;44(Pt 6):1281-1284
pubmed: 22477785
J Agric Food Chem. 2012 Aug 22;60(33):8123-8
pubmed: 22812915
Pharmacogn Mag. 2014 Jan;10(37):73-6
pubmed: 24696549